Events

Featured event

Featured Event

[Webinar] A Lipid Nanoparticle Quantitative Systems Pharmacology Case Study

Aired Live September 12, 2018 | 2pm ET / 11am PT

View Webinar

Upcoming Events

Sep

World Bispecific

09/19/2018 - 7:30am

Oct

ACoP9

10/07/2018 - 8:00am

Oct

Quantitative Systems Pharmacology (QSP) Industry & Academia Symposium

10/25/2018 - 5:45pm

Nov

PharmSci 360

11/04/2018 - 8:00am

Nov

[Webinar] Predicting Optimal Drug Properties of a Bispecific Biologic to Maximize Tissue Targeting in Osteoarthritis

11/08/2018 - 2:00pm

Nov

Paws for a Cure Research Symposium

11/12/2018 - 8:00am

Nov

Drug Development Boot Camp

11/14/2018 - 7:00am

Apr

Quantitative Systems Pharmacology (QSP) Summit

04/25/2019 - 8:00am

Past Events

Sep

[Webinar] A Lipid Nanoparticle Quantitative Systems Pharmacology Case Study

09/12/2018 - 2:00pm

Speaker Information
Pratap Singh, PhD, Director of Pharmacometrics and Quantitative Clinical Pharmacology, Alexion Pharmaceuticals

Sep

PBSS San Francisco | Antibody Drug Conjugate Workshop

09/12/2018 - 8:45am

Apr

PEGS: The Essential Protein Engineering Summit

04/30/2018 - 8:00am

Apr

PBSS Boston | Dose Projection for First-in-Human Studies Workshop

04/27/2018 - 8:00am

Apr

Quantitative Systems Pharmacology (QSP) Day

04/12/2018 - 9:00am

Mar

[Webinar] How a Good Regulatory and Computational Strategy Helps Avoid Common Pitfalls

03/06/2018 - 2:00pm

Speaker Information
Lorna Speid, PhD, Founder and President, Speid & Associates, Inc.

Nov

[Webinar] Quantitative Modeling & Simulation: Driving Critical Decisions from Research through Clinical Trials

11/07/2017 - 1:00pm

Speaker Information
John M. Burke, PhD, CO-Founder, President and CEO, Applied BioMath

Sep

[Webinar] Exploring ADC Pharmacokinetics Using QSP Modeling Strategies

09/13/2017 - 2:00pm

Speaker Information
Joshua Apgar, PhD, Co-Founder and CSO, Applied BioMath

Apr

[Webinar] QSP Modeling for Dual Targeting Approaches for Two Immuno-oncology Therapeutics

04/12/2016 - 2:00pm

Speaker Information
John M. Burke, PhD, CO-Founder, President and CEO, Applied BioMath